RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
- Conditions
- Peripheral Artery DiseaseAtherosclerosisArtery Diseases, PeripheralPlaque, AtheroscleroticOcclusive Arterial Disease
- Interventions
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 440
- Registration Number
- NCT03064126
- Locations
- 🇺🇸
Thomas Hospital, Fairhope, Alabama, United States
🇺🇸Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States
🇺🇸The Vascular Experts, Stratford, Connecticut, United States
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
- Conditions
- Cardiac Arrythmias
- Interventions
- Device: Rhythmia Mapping System
- First Posted Date
- 2017-02-14
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT03053141
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸St. Lukes Idaho Cardiology Associates, Boise, Idaho, United States
🇺🇸Lahey Clinic, Inc., Burlington, Massachusetts, United States
Performance and Safety of the Lotus™ Valve With a FLEXible Delivery System
- Conditions
- Aortic Stenosis
- Interventions
- Device: Transcatheter aortic valve replacement
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 4
- Registration Number
- NCT03043404
- Locations
- 🇦🇺
Prince Charles Hospital, Chermside, Queensland, Australia
🇦🇺Monash Heart, Clayton, Victoria, Australia
Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation
- Conditions
- Parkinson Disease
- Interventions
- Device: Vercise Deep Brain Stimulation System
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 72
- Registration Number
- NCT03037398
- Locations
- 🇩🇪
University Berlin, Charite Virchow Standort, Wedding, Berlin, Germany
🇩🇪Universitaetsklinik Eppendorf, Hamburg, Germany
🇩🇪Universitätsklinikum Campus Kiel, Kiel, Germany
A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries
- Conditions
- Vascular DiseasesArterial Occlusive DiseasesAtherosclerosisArteriosclerosis
- Interventions
- Device: Peripheral stenting
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 291
- Registration Number
- NCT03037411
- Locations
- 🇦🇹
Medizinische Universität Graz, Graz, Austria
🇧🇪ZOL Genk, Genk, Limburg, Belgium
🇧🇪Regionaal Ziekenhuis Heilig Hart Tienen, Tienen, Vlaams-Brabant, Belgium
Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial
- Conditions
- Chronic Pain
- Interventions
- Device: Programming
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 35
- Registration Number
- NCT02988713
- Locations
- 🇺🇸
Pacific Pain Management, Inc., Ventura, California, United States
🇺🇸PCPMG Clinical Research Unit, LLC, Greenville, South Carolina, United States
REPRISE EDGE 29 mm EU Study
- Conditions
- Aortic Valve Stenosis
- Interventions
- Device: 29 mm LOTUS Edge™ Valve System
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- Boston Scientific Corporation
- Registration Number
- NCT02964962
Ranger™ and Ranger™ SL (OTW) DCB) in China
- Conditions
- Femoropopliteal Artery Lesions
- Interventions
- Device: Boston Scientific Ranger™ and Ranger™ SL Paclitaxel-Coated PTA Balloon Catheter
- First Posted Date
- 2016-10-25
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 123
- Registration Number
- NCT02944071
- Locations
- 🇨🇳
Beijing Tongren Hospital, Capital Medical University, BeiJing, Beijing, China
🇨🇳The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
🇨🇳Jiangsu Province Hospital, Nanjing, Jiangsu, China
Rezum I Pilot Study for Benign Prostatic Hyperplasia
- Conditions
- Prostatic AdenomaProstatic HyperplasiaProstatic HypertrophyRezumBenign Prostatic HyperplasiaAdenoma, ProstaticProstatic Hyperplasia, BenignProstatic Hypertrophy, Benign
- Interventions
- Device: Rezum System
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2021-03-16
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 50
- Registration Number
- NCT02943070
- Locations
- 🇨🇿
University Hospital, Brno, Czechia
🇩🇴Clinica Canela, La Romana, Dominican Republic
🇸🇪Urologcentrum, Stockholm, Sweden
Rezum FIM Optimization Study
- Conditions
- Adenoma, ProstaticProstatic AdenomaRezumBenign Prostatic HyperplasiaProstatic Hypertrophy, BenignProstatic Hyperplasia, BenignProstatic Hypertrophy
- Interventions
- Device: Rezum System
- First Posted Date
- 2016-10-20
- Last Posted Date
- 2021-03-05
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT02940392
- Locations
- 🇩🇴
Clinica Canela, La Romana, Dominican Republic